PVALB and retinal disorder: Pharmacological inhibition of STEP with TC-2153 for four months during the active progression of AMD-like retinopathy had a negative effect on relative thickness of the retinal INL, as evidenced by a decrease in the amount of parvalbumin-positive amacrine neurons.